Also trades as: ESLAW (NASDAQ) · $vol 0M
ESLA NASDAQ
Estrella Immunopharma, Inc.
1W: -2.7%
1M: -32.2%
3M: -54.1%
YTD: -66.3%
1Y: -65.1%
3Y: -95.7%
5Y: -95.2%
$0.47
-0.01 (-1.47%)
Weekly Expected Move ±12.3%
$0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-10M
Net Income
+17.1% YoY
$-9M
Free Cash Flow
-134.9% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE148.1%
ROA-416.7%
ROIC102.1%
Valuation
P/E-1.9
P/B-2.7
EV/EBITDA-4.6
Leverage
Debt/Equity0.00
Current Ratio0.20
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-51.60
Beneish M0.00